EP3307877
METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.6.2016EP published:
18.11.2020EP application number:
16808492.9
EPO information:
European Patent Register
Max expiry date:
11.6.2036
Title:
METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS
Timeline
Today
12.6.2016EP application
18.11.2020EP Publication
Owner
Name:
Lentigen Technology, Inc.Address:
910 Clopper Road, Suite 200S, Gaithersburg, MD 20878, US
Inventor
Name:
DROPULIC, BoroAddress:
Ellicott City, MD 21042, US
Name:
ORENTAS, RimasAddress:
Washington, DC 20008, US
Name:
SCHNEIDER, DinaAddress:
Potomac, MD 20854, US
Name:
KRUEGER, WinfriedAddress:
Kensington, MD 20895, US
Priority
Number:
201562175003 PDate:
12.6.2015Country:
US
Classification
Categories:
A61K 35/17, A61K 38/17, A61P 7/00, A61P 35/00, A61P 35/02, C07K 14/725, C12N 5/0783